Sajid Iqbal
Sajid Iqbal has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Gaofeng Shu
Zhejiang Key Laboratory of Imaging and Interventional Medicine, Zhejiang Engineering Research Center of Interventional Medicine Engineering and Biotechnology, Lishui Hospital of Zhejiang University, Lishui, 323000, China
2 shared publications- Jiansong Ji
Department of Radiology, Lishui Hospital of Zhejiang University, Lishui, China
2 shared publications Minjiang Chen
Zhejiang Key Laboratory of Imaging and Interventional Medicine, Zhejiang Engineering Research Center of Interventional Medicine Engineering and Biotechnology, Lishui Hospital of Zhejiang University, Lishui, 323000, China
2 shared publicationsShiji Fang
Zhejiang Key Laboratory of Imaging and Interventional Medicine, Zhejiang Engineering Research Center of Interventional Medicine Engineering and Biotechnology, Lishui Hospital of Zhejiang University, Lishui, 323000, China
2 shared publications- Yongzhong Du
Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, PR China
2 shared publications Fazong Wu
Zhejiang Key Laboratory of Imaging and Interventional Medicine, Zhejiang Engineering Research Center of Interventional Medicine Engineering and Biotechnology, Lishui Hospital of Zhejiang University, Lishui, 323000, China
1 shared publication
Latest Publications
- 4 November 2024
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 12 (24) , 6368-6381
Self-targeted smart polyester nanoparticles for simultaneous Delivery of photothermal and chemotherapeutic agents for efficient treatment of HCC
Advances in nanotechnology offer promising strategies to overcome the limitations of single-drug therapies in hepatocellular carcinoma (HCC) and other cancers such as multidrug resistance and variable drug tolerances. This study proposes a targeted nanoparticle system based on a poly(β-aminoester) (PβAE) core and a hyaluronic acid (HA) shell, designed for the codelivery of doxorubicin (DOX) and indocyanine green (ICG) to effectively treat HCC. These nanoparticles demonstrated remarkable physicochemical and colloidal stability, pH- and temperature-responsive release, enhanced cellular uptake, and drug retention within tumors. Upon near-infrared (NIR) irradiation, the photothermal conversion of ICG elevated local tumor temperatures up to 53.6 °C, enhancing apoptotic cell death significantly compared to chemotherapy alone (p < 0.05). Furthermore, the dual delivery system significantly enhanced therapeutic efficacy, as evidenced by a marked decrease in tumor growth in vivo compared to controls (p < 0.01). These findings illustrate that the HA/PβAE/DOX/ICG nanoparticles are not only able to precisely target tumor cells but also overcome the limitations associated with traditional chemotherapies and photothermal treatments, suggesting a promising avenue for clinical translation of cancer therapy.
- 4 November 2024
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 12 (24) , 6368-6381
Self-targeted smart polyester nanoparticles for simultaneous Delivery of photothermal and chemotherapeutic agents for efficient treatment of HCC
Advances in nanotechnology offer promising strategies to overcome the limitations of single-drug therapies in hepatocellular carcinoma (HCC) and other cancers such as multidrug resistance and variable drug tolerances. This study proposes a targeted nanoparticle system based on a poly(β-aminoester) (PβAE) core and a hyaluronic acid (HA) shell, designed for the codelivery of doxorubicin (DOX) and indocyanine green (ICG) to effectively treat HCC. These nanoparticles demonstrated remarkable physicochemical and colloidal stability, pH- and temperature-responsive release, enhanced cellular uptake, and drug retention within tumors. Upon near-infrared (NIR) irradiation, the photothermal conversion of ICG elevated local tumor temperatures up to 53.6 °C, enhancing apoptotic cell death significantly compared to chemotherapy alone (p < 0.05). Furthermore, the dual delivery system significantly enhanced therapeutic efficacy, as evidenced by a marked decrease in tumor growth in vivo compared to controls (p < 0.01). These findings illustrate that the HA/PβAE/DOX/ICG nanoparticles are not only able to precisely target tumor cells but also overcome the limitations associated with traditional chemotherapies and photothermal treatments, suggesting a promising avenue for clinical translation of cancer therapy.
- 17 July 2023
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 11 (18) , 6109-6115
Biomaterials evolution: from inert to instructive
The Evolution of Biomaterials: A Remarkable Journey Fueled by Materials Science and Engineering Advancements, redefining the landscape of the biomaterials field.
- 17 July 2023
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 11 (18) , 6109-6115
Biomaterials evolution: from inert to instructive
The Evolution of Biomaterials: A Remarkable Journey Fueled by Materials Science and Engineering Advancements, redefining the landscape of the biomaterials field.
- 1 January 2022
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 611, 121289
Poly (β amino esters) copolymers: Novel potential vectors for delivery of genes and related therapeutics
- 1 January 2022
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 611, 121289
Poly (β amino esters) copolymers: Novel potential vectors for delivery of genes and related therapeutics